SSY GROUP(02005): The full range C-reactive protein (hsCRP+conventional CRP) detection reagent kit and serum amyloid protein A/C-reactive protein (SAA/CRP) detection reagent kit have been issued with a medical device registration certificate by the Hebei Food and Drug Administration of China.

SSY GROUP (02005) announced that the full-range C-reactive protein (hsCRP+ conventional CRP) assay kit (fluorescence immunochromatography method) and the serum amyloid protein A/C-reactive protein (SAA/CRP) assay kit (fluorescence immunochromatography method) have received medical device registration certificates from the Hebei Province Drug Administration in China. The full-range C-reactive protein (hsCRP+ conventional CRP) assay kit is used for in vitro quantitative detection of the content of C-reactive protein in whole blood, serum, and plasma samples, clinically used for the auxiliary diagnosis of non-specific inflammation and cardiovascular diseases. The serum amyloid protein A/C-reactive protein (SAA/CRP) assay kit is used for in vitro quantitative detection of the content of serum amyloid protein A (SAA) and C-reactive protein (CRP) in human serum/plasma/whole blood samples, clinically used for the auxiliary diagnosis of non-specific inflammation. The consecutive approval of multiple assay kits paves the way for the group to develop new tracks in the medical device products.